Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
3-(4-Bromophenyl)-5-methyl-1,2,4-oxadiazole → N-Cyclopropyl-6-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-3-carboxamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 3-(4-Bromophenyl)-5-methyl-1,2,4-oxadiazole | HCID 823560 | — |
| 반응물 | N-cyclopropyl-4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | HCID 21914577 | — |
| 생성물 | N-Cyclopropyl-6-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-3-carboxamide | HCID 44580359 | — |
반응 단계
Example 7 was prepared using 3-(4-bromophenyl)-5-methyl-1,2,4-oxadiazole and N-cyclopropyl-4-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]-dioxaborolan-2-yl)benzamide (Intermediate 17).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07425555B2 |
| 출처 데이터셋 | uspto-grants-2008_09 |
| ORD ID | ord-f6ce99ff3e294b898b5ca24b508782d2 |
| 출처 메모 | uspto-grants-2008_09 |